LEIDOS BIOMEDICAL RESEARCH INC - PRODUCING USHER III RETINAL ORGANOIDS FROM PATIENT CELLS TO MEASURE THE EFFECT OF DRUG CANDIDATE

PIID: 75N91025F00020

Signed Date: Jan 30, 2026Effective Date: Sep 15, 2025End Date: Closes in 508 days

Award $

$795K

Vendor

LEIDOS BIOMEDICAL RESEARCH INC

NAICS

541715

Signed Date

Jan 30, 2026

Key Details

Dollars Obligated

$794,843

Base & All Options

Awarding Agency

Awarding Sub-Agency

National Institutes of Health

NAICS Code

Product Service Code

AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH

Extent Competed

FULL AND OPEN COMPETITION

Place of Performance

FREDERICK, MD, 217029242, CD-MD-06

PRODUCING USHER III RETINAL ORGANOIDS FROM PATIENT CELLS TO MEASURE THE EFFECT OF DRUG CANDIDATE

On Jan 30, 2026, Department of Health and Human Services obligated $794,843 to LEIDOS BIOMEDICAL RESEARCH INC for producing usher iii retinal organoids from patient cells to measure the effect of drug candidate. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in FREDERICK, MD. The contract is scheduled through Mar 15, 2028 — approximately 17 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.